Lonza | LONN - Net Income

Stock Price
481.50
Daily Change
-6.80 -1.39%
Monthly
-10.54%
Yearly
-15.02%
Q1 Forecast
468.93

Lonza reported CHF307M in Net Income for its fiscal semester ending in December of 2024.





Net Income Change Date
Akzo Nobel EUR 598M 792M Dec/2025
Alcon AG USD 217M 20M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
BASF EUR 560M 388M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Beiersdorf EUR 387M 165M Dec/2025
Covestro EUR -378M 331M Dec/2025
Demant DKK 427M 690M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Geberit CHF 151.2M 36.1M Jun/2025
Genmab DKK 336M 141M Jun/2025
Givaudan CHF 294M 150M Jun/2024
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GN Store Nord DKK 344M 271M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Johnson Matthey GBP -18M 93M Dec/2025
Merck EUR 319M 583M Dec/2025
Novartis USD 3.93B 96M Sep/2025
Philips EUR 395M 211M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Sika AG CHF 553.8M 115.8M Jun/2025
Smith & Nephew USD 293M 79M Dec/2025
Solvay EUR -95M 129M Dec/2025
UCB EUR 857M 649M Dec/2024